Choose which categories of cookies you allow. Strictly necessary cookies are always on.
Required for core site functionality, security and your session. Always active.
Help us understand how visitors use the site (e.g. Google Analytics) so we can improve it.
Used to measure campaigns and show you relevant ads on other sites (e.g. LinkedIn, Google Ads).
|
Sr. No. |
Item |
Description |
|
1 |
Company Name |
Bayer AG |
|
2 |
Website |
www.bayer.com |
|
3 |
Established Date |
1863 |
|
4 |
Headquartered |
Germany |
|
5 |
Market Position/ History |
Bayer's journey began in 1863 when Friedrich Bayer, a dye salesman, and Johann Friedrich Weskott, a master dyer, established the partnership “Friedr. Bayer et comp.” This venture quickly gained momentum, laying the groundwork for significant growth. By 1881, the transformation into a joint-stock company provided a robust financial framework for expansion. Under the leadership of Carl Duisberg, Bayer expanded its scope beyond dyestuffs to encompass diverse chemical innovations, establishing itself as an internationally recognized entity by the early 20th century. In more recent years, Bayer has undergone transformative changes to adapt to global challenges and opportunities. The 2010s marked a period of strategic investments, including the acquisition of Monsanto and the spin-off of Covestro. As part of its commitment to sustainability and innovation, Bayer launched initiatives in cell and gene therapy. In 2023, a new chapter began with the retirement of CEO Werner Baumann and the appointment of Bill Anderson, marking a renewed focus on driving the company into a future defined by sustainable growth and groundbreaking scientific advancements. |
|
6 |
Sales Area |
Worldwide |
|
7 |
Manufacturing Location |
Worldwide |
|
8 |
Ticker |
NSE: BAYERCROP |
|
9 |
No. of Employees |
99,723 (As of 2023) |
|
10 |
Competitors |
|
|
11 |
CEO |
Bill Anderson |
|
12 |
Ownership Type |
Public |
|
13 |
Contact Information |
Address: 51368 Leverkusen, Germany Tel: +49 214 30-1 |
Bayer AG operates under three business segments:
Crop Science: This category focuses on developing, producing, and marketing a broad range of products, including seeds, plant traits, crop protection solutions, digital tools, and customer services, all aimed at promoting sustainable agriculture.
Pharmaceuticals: It involves the development, production, and marketing of prescription products, particularly for cardiology and women's health, as well as specialty therapeutics in oncology, hematology, ophthalmology, and emerging fields like cell and gene therapy, alongside diagnostic imaging equipment and contrast agents.
Consumer Health: This segment specializes in the development, production, and marketing of primarily nonprescription (OTC) products, including those for dermatology, nutritional supplements, digestive health, allergies, cough and cold, pain relief, and cardiovascular risk prevention.
|
Product |
Product Description |
|
Premise SC200 |
Key Product Facts:
|
|
Agenda 25 EC |
Key Product Facts:
|
Need a tailored company profile or competitive intelligence report? Our analysts are ready to help.
Contact Our ExpertsExplore all published company profiles across 30+ industry verticals.
View All Profiles